Alnylam Pharmaceuticals, Inc.
- Stock
- Ticker ALNY
- ISIN US02043Q1076
- Nasdaq
Performance, volatility and drawdowns of Alnylam Pharmaceuticals, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $30,503. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −70.7% in 11/2026, measured from the peak in 10/2025. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 593 | 594 | 774 | 1,249 | 1,097 | – | 1,291 | 1,458 |
| Gross profit | 491 | 524 | 632 | 1,052 | 829 | – | 993 | 1,096 |
| Operating income | -105 | 18 | -16 | 368 | 132 | – | 231 | 346 |
| EBITDA | -91 | 32 | -2.3 | 382 | 145 | – | – | 360 |
| Net income | -84 | -18 | -72 | 293 | 112 | 206 | 164 | 2,167 |
| Earnings per share | -0.65 | -0.14 | -0.55 | 2.14 | 0.82 | – | 1.21 | 15.72 |
| Balance sheet | ||||||||
| Total assets | 4,240 | 4,214 | 4,566 | 4,852 | 4,966 | – | 5,559 | 7,995 |
| Liabilities | 4,173 | 4,098 | 4,315 | 4,618 | 4,177 | – | 4,205 | 4,391 |
| Equity | 67 | 426 | 555 | 580 | 789 | 1,075 | 1,354 | 3,604 |
| Cash | 966 | 1,020 | 1,114 | 1,490 | 1,657 | – | 1,708 | 1,754 |
| Cash flow | ||||||||
| Operating cash flow | -95 | -118 | 128 | 297 | 218 | – | – | 341 |
| Capital expenditure | -9.1 | -9.0 | -14 | -12 | -23 | – | – | -70 |
| Free cash flow | -104 | -127 | 114 | 285 | 194 | – | – | 271 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2017 at +239.3%, weakest 2018 at −42.6%. 7 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 29 Oct 2026 | $15.72 |
| 30 Jul 2026 | $1.21 |
| 12 Feb 2026 | $0.82 |
| 30 Oct 2025 | $2.14 |
| 31 Jul 2025 | −$0.55 |
| 1 May 2025 | −$0.14 |
| 13 Feb 2025 | −$0.65 |
| 31 Oct 2024 | −$0.87 |
| 1 Aug 2024 | −$0.13 |
| 2 May 2024 | −$0.52 |
| 15 Feb 2024 | −$1.09 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €17bn
- Market cap in trading currency
- $19.3bn
- Enterprise value
- $15.7bn
- P/E
- –
- P/S
- –
- P/B
- 5.35
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- –
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- –
- Net income
- $2.65bn
- Earnings per share
- –
- Revenue per share
- –
- Revenue growth
- +16.7%
- Earnings growth
- +640.5%
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- 126.6%
- Return on assets
- 33.1%
Balance sheet and cash flow
- Cash
- $3.59bn
- Cash per share
- $26.78
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 2.48
- Book value per share
- $26.91
- Operating cash flow
- –
- Free cash flow
- –
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 134m
- Volume
- 2.32m
- Avg. volume 3 months
- 2.06m
- Relative volume
- 1.1
Price and technicals
- Price
- $143.82
- 1 day
- −2.7%
- 52-week high
- $473.29
- 52-week low
- $143.82
- Distance to 52-week high
- −69.6%
- Distance to 52-week low
- 0.0%
- Distance to 50-day line
- −31.1%
- Distance to 200-day line
- −46.9%
- RSI (14)
- 26
- Volatility 1M
- 107.7%
Performance
- 1 week
- −12.9%
- 1 month
- −36.7%
- 3 months
- −39.1%
- 6 months
- −51.6%
- YTD
- −63.8%
- 1 year
- −68.8%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has ALNY performed since 11/2016?
$10,000 grew to $30,503 by 20 Nov 2026, which is +11.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is ALNY?
Volatility was 48.8% per year, measured on monthly returns. The largest decline from a peak was −70.7%, with the low in 11/2026.
How does ALNY compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ALNY returned +11.8% at 48.8%. The correlation of monthly returns was 0.21; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.